Preparation and evaluation of radiolabeled gliclazide parenteral nanoemulsion as a new tracer for pancreatic β-cells mass

References

• Aguilar-Bryan L, Bryan J. 1999. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev. 20(2):101–135.
   PubMed Web of Science ®Google Scholar
• Araújo FA, Kelmann RG, Araújo BV, Finatto RB, Teixeira HF, Koester LS. 2011. Development and characterization of parenteral nanoemulsions containing thalidomide. Eur J Pharm Sci. 42(3):238–245.
   PubMed Web of Science ®Google Scholar
• Aronson JK. 2016. Radioactive iodine. In: Aronson JK, editor. Meyler’s Side Effects of Drugs. 16th ed. Oxford: Elsevier; p. 49–54.
   Google Scholar
• Bini J, Naganawa M, Nabulsi N, Huang Y, Ropchan J, Lim K, Najafzadeh S, Herold KC, Cline GW, Carson RE. 2018. Evaluation of PET brain radioligands for imaging pancreatic β-cell mass: potential utility of (11)C-(+)-PHNO. J Nucl Med. 59(8):1249–1254.
   PubMed Web of Science ®Google Scholar
• Brom M, Woliner-van der Weg W, Joosten L, Frielink C, Bouckenooghe T, Rijken P, Andralojc K, Göke BJ, de Jong M, Eizirik DL, et al. 2014. Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin. Diabetologia. 57(5):950–959.
   PubMed Web of Science ®Google Scholar
• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52(1):102–110.
   PubMed Web of Science ®Google Scholar
• Buyukozturk F, Benneyan JC, Carrier RL. 2010. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release. 142(1):22–30.
   PubMed Web of Science ®Google Scholar
• Cai W, Calder PC, Cury-Boaventura MF, De Waele E, Jakubowski J, Zaloga G. 2018. Biological and clinical aspects of an olive oil-based lipid emulsion-a review. Nutrients. 10(6):776.
   PubMed Web of Science ®Google Scholar
• Choong W-S, Moses WW, Tindall CS, Luke PN. 2005. Design for a high-resolution small-animal spect system usingpixellated Si(Li) detectors for in vivo Iodine-125 imaging. IEEE Trans Nucl Sci. 52(1):174–180.
   Web of Science ®Google Scholar
• El-Kawy OA, Abdel-Razek AS, Sayed MS. 2016. Radiolabeling, biological evaluation and molecular docking of delafloxacin: a novel methicillin-resistant Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. 308(3):1081–1088.
   Web of Science ®Google Scholar
• El-Kawy OA, Abdelaziz G. 2022. Preparation, characterization and evaluation of [125I]-pirarubicin: a new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent. Appl Radiat Isot. 179:110007.
   PubMed Web of Science ®Google Scholar
• El-Kawy OA, García-Horsman JA. 2017a. 99mTc-labeled glimepiride as a tracer for targeting pancreatic β-cells mass: preparation and preclinical evaluation. J Radioanal Nucl Chem. 314(3):2539–2550.
   Web of Science ®Google Scholar
• El-Kawy OA, García-Horsman JA. 2017b. 99mTc-roxifiban: a potential molecular imaging agent for the detection and localization of acute venous thrombosis. J Radioanal Nucl Chem. 311(3):1719–1728.
   Web of Science ®Google Scholar
• El-Kawy OA, Shweeta HA, Attallah KM. 2022. Radioiodination, nasal nanoformulation and preliminary evaluation of isovanillin: a new potential brain cancer-targeting agent. Appl Radiat Isot. 189:110464.
   PubMed Web of Science ®Google Scholar
• El‐Kawy OA, Hashem AM, Amin MA, El‐Wetery AS. 2009. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy. J Label Compd Radiopharm. 52(3):91–97.
   Web of Science ®Google Scholar
• El‐Kawy OA, Hashem AM, Amin MA, El‐Wetery AS. 2011. Preparation and evaluation of [125I]troxacitabine: L‐nucleoside model of a potential agent for tumor diagnosis and radiotherapy. J Label Compd Radiopharm. 54(2):98–104.
   Web of Science ®Google Scholar
• Eriksson O. 2019. GPR44 as a target for imaging pancreatic beta-cell mass. Curr Diab Rep. 19(8):49.
   PubMed Web of Science ®Google Scholar
• Eriksson O, Laughlin M, Brom M, Nuutila P, Roden M, Hwa A, Bonadonna R, Gotthardt M. 2016. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use. Diabetologia. 59(7):1340–1349.
   PubMed Web of Science ®Google Scholar
• Glieberman AL, Pope BD, Melton DA, Parker KK. 2021. Building biomimetic potency tests for islet transplantation. Diabetes. 70(2):347–363.
   PubMed Web of Science ®Google Scholar
• Harun SN, Nordin SA, Gani SSA, Shamsuddin AF, Basri M, Basri HB. 2018. Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics. Int J Nanomedicine. 13:2571–2584.
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Dudhe R, Sharma PK. 2015. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 5(2):123–127.
   PubMedGoogle Scholar
• Kamble M, Borwandkar VG, Mane SS, Mane OR, Aute PP, Chaudhari P. 2012. Formulation and evaluation of lipid based nanoemulsion of glimepiride using self-emulsifying technology. Indo Am J Pharm Res. 2:1011–1025.
   Google Scholar
• Khalil R, Basha M, Kamel R. 2015. Nanoemulsions as parenteral drug delivery systems for a new anticancer benzimidazole derivative: formulation and in-vitro evaluation. Egypt Pharmaceut J. 14(3):166–173.
   Google Scholar
• Matveyenko AV, Butler PC. 2008. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab. 10(04):23–31.
   PubMedGoogle Scholar
• Michelotti FC, Bowden G, Küppers A, Joosten L, Maczewsky J, Nischwitz V, Drews G, Maurer A, Gotthardt M, Schmid AM, et al. 2020. PET/MRI enables simultaneous in vivo quantification of β-cell mass and function. Theranostics. 10(1):398–410.
   PubMed Web of Science ®Google Scholar
• Motaleb MA, Shweeta HA, Aboumanei MH. 2022. Radio-iodination and biological evaluation of pentoxifylline as a novel probe for diagnosis of intermittent claudication. Appl Radiat Isot. 189:110429.
   PubMed Web of Science ®Google Scholar
• Najlah M, Kadam A, Wan K-W, Ahmed W, Taylor KMG, Elhissi AMA. 2016. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines. Int J Pharm. 506(1–2):102–109.
   PubMedGoogle Scholar
• Nasr M, Almawash S, Al Saqr A, Bazeed AY, Saber S, Elagamy HI. 2021. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals. 14(8):786.
   Web of Science ®Google Scholar
• Nazief AM, Hassaan PS, Khalifa HM, Sokar MS, El-Kamel AH. 2020. Lipid-based gliclazide nanoparticles for treatment of diabetes: formulation, pharmacokinetics, pharmacodynamics and subacute toxicity study. Int J Nanomed. 15:1129–1148.
   PubMed Web of Science ®Google Scholar
• Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K, Skovronsky DM, Herold KC, McCarthy TJ, Calle RA, et al. 2012. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med. 53(6):908–916.
   PubMed Web of Science ®Google Scholar
• Patel H, Pandey N, Patel B, Ranch K, Bodiwala K, Vyas B. 2020. Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form. Futur J Pharm Sci. 6(1):17.
   Web of Science ®Google Scholar
• Payolla FB, Massabni AC, Orvig C. 2019. Radiopharmaceuticals for diagnosis in nuclear medicine: a short review. Eclét Quím J. 44(3):11–19.
   Google Scholar
• Puri K, Suresh K, Gogtay N, Thatte U. 2009. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 55(2):131–134.
   PubMed Web of Science ®Google Scholar
• Razzaq FA, Asif M, Asghar S, Iqbal MS, Khan IU, Khan S-U-D, Irfan M, Syed HK, Khames A, Mahmood H, et al. 2021. Glimepiride-loaded nanoemulgel; development, in vitro characterization, ex vivo permeation and in vivo antidiabetic evaluation. Cells. 10(9):2404.
   PubMed Web of Science ®Google Scholar
• Roethlisberger D, Mahler HC, Altenburger U, Pappenberger A. 2017. If euhydric and isotonic do not work, what are acceptable pH and osmolality for parenteral drug dosage forms? J Pharm Sci. 106(2):446–456.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 157:107843.
   PubMed Web of Science ®Google Scholar
• Saepudin Morrissey H, Ball P, Abdel-Aziz F, Nugroho BH. 2018. Formulation of gliclazide using self-nano-emulsification technology. Eur J Biomed Pharm Sci. 5(5):29–39.
   Google Scholar
• Sakr TM, Ibrahim IT, Abd-Alla WH. 2018. Molecular modeling and preclinical evaluation of radioiodinated tenoxicam for inflammatory disease diagnosis. J Radioanal Nucl Chem. 316(1):233–246.
   Web of Science ®Google Scholar
• Sala-Vila A, Barbosa VM, Calder PC. 2007. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 10(2):165–174.
   PubMed Web of Science ®Google Scholar
• Sanad MH, Talaat HM, Ibrahim IT, Saleh GM, Abouzeid LA. 2018. Radioiodinated celiprolol as a new highly selective radiotracer for β1-adrenoceptor-myocardial perfusion imaging. Radiochimica Acta. 106(9):751–757.
   Web of Science ®Google Scholar
• Saudek F, Brogren CH, Manohar S. 2008. Imaging the beta-cell mass: why and how. Rev Diabet Stud. 5(1):6–12.
   PubMedGoogle Scholar
• Swithenbank L, Cox P, Harris LG, Dudley E, Sinclair K, Lewis P, Cappiello F, Morgan C. 2020. Temporin A and Bombinin H2 antimicrobial peptides exhibit selective cytotoxicity to lung cancer cells. Scientifica. 2020:3526286.
   PubMed Web of Science ®Google Scholar
• Vallabhajosula S. 2015. Radiopharmaceuticals in molecular imaging. In: Jaeger D, Jung R, editors. Encyclopedia of computational neuroscience. New York (NY): Springer; p. 2557–2582.
   Google Scholar
• Wang J-J, Sung KC, Hu OY-P, Yeh C-H, Fang J-Y. 2006. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release. 115(2):140–149.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zheng X, Zhang H, Zhai J, Zhang L, Li C, Zeng K, Chen Y, Li Q, Hu X. 2015. In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis. Chem Biol Interact. 240:310–315.
   PubMed Web of Science ®Google Scholar
• Zhong F, Jiang Y. 2019. Endogenous pancreatic β cell regeneration: a potential strategy for the recovery of β cell deficiency in diabetes. Front Endocrinol. 10:101.
   PubMed Web of Science ®Google Scholar